Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes 2013;6:453-67.
Ehrenkranz JR, Lewis NG, Kahn CR, Roth J. Phlorizin: a review. Diabetes Metab Res Rev 2005;21(1):31-38.
Masumoto S, Akimoto Y, Oike H, Kobori M. Dietary phloridzin reduces blood glucose levels and reverses Sglt1 expression in the small intestine in streptozotocin-induced diabetic mice. J Agric Food Chem 2009;57(11):4651-4656.
Bradford BJ, Allen MS. Phlorizin induces lipolysis and alters meal patterns in both early- and late-lactation dairy cows. J Dairy Sci 2007;90(4):1810-1815.
Proksa B, Uhrin D, Odonmazhig P, Badga D. Isolation of phlorizin from leaves of Armeniaca sibirica. Pharmazie 1988;43(9):658-659.
Zhao H, Yakar S, Gavrilova O, et al. Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes. Diabetes 2004;53(11):2901-2909.
Zhang S, Zhu M, Shen D. Experimental study on the treatment of diabetes by phloridzin in rats. J Tongji Med Univ 1998;18(2):105-7, 118.
Starke A, Grundy S, McGarry JD, Unger RH. Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes. Proc Natl Acad Sci USA 1985;82(5):1544-1546.
Crespy V, Aprikian O, Morand C, et al. Bioavailability of phloretin and phloridzin in rats. J Nutr 2001;131(12):3227-3230.
Makarova E, Górnas P, Konrade I, et al. Acute anti-hyperglycaemic effects of an unripe apple preparation containing phlorizin in healthy volunteers: a preliminary study. J Sci Food Agric. 2015;95(3):560-8.
Zhang XY, Yi K, Chen J, et al. Purified phlorizin from DocynIa indica (Wall.) Decne by HSCCC, compared with whole extract, phlorizin and non-phlorizin fragment ameliorate obesity, insulin resistance, and improves intestinal barrier function in high-fat-diet-fed mice. Molecules. 2018;23(10). pii: E2701.
Ishida E, Kim-Muller JY, Accili D. Pair feeding, but not insulin, phloridzin, or rosiglitazone treatment, curtails markers of β-cell dedifferentiation in <em>db/db</em> mice. Diabetes. 2017;66(8):2092-2101.
Chao EC, Henry RR. SGLT2 inhibition--a novel strategy for diabetes treatment. Nat Rev Drug Discov. 2010;9(7):551-9.